MedPath

Poliovirus type 2 antigen (formaldehyde inactivated)

Generic Name
Poliovirus type 2 antigen (formaldehyde inactivated)
Brand Names
Ipol, Kinrix, Pediarix, Pentacel, Quadracel, Vaxelis
Drug Type
Biotech
Unique Ingredient Identifier
23JE9KDF4R

Overview

Poliovirus type 2 antigen is a suspension of poliovirus Type 2 (MEF-1) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 2. The vaccine contains purified and inactivated poliovirus type 2 that were grown from a continuous line of monkey kidney cells.

Indication

No indication information available.

Associated Conditions

  • Poliomyelitis caused by Poliovirus
  • Poliomyelitis caused by poliovirus type 2

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
A-S Medication Solutions
50090-7541
INTRAMUSCULAR
8 [iU] in 0.5 mL
8/13/2025
GlaxoSmithKline Biologicals SA
58160-812
INTRAMUSCULAR
8 [iU] in 0.5 mL
11/26/2024

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
HEXAXIM SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
SIN14834P
INJECTION, SUSPENSION
40 DU/0.5 mL
8/25/2015
HEXAXIM SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
SIN14834P
INJECTION, SUSPENSION
8 DU/0.5 mL
8/25/2015
INFANRIX HEXA VACCINE
SIN12288P
INJECTION
8 du/0.5 ml
5/7/2003
BOOSTRIX POLIO SUSPENSION FOR INJECTION
SIN15888P
INJECTION, SUSPENSION
8 DU/0.5 ml
2/20/2020
Tetraxim Vaccine
SIN15026P
INJECTION, SUSPENSION
8 DU/0.5ml
6/6/2016

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
INFANRIX-IPV
02241284
Suspension - Intramuscular
8 UNIT / 0.5 ML
10/25/2012
INACTIVATED POLIOMYELITIS VACCINE (DIPLOID CELL ORIGIN) - IPV
02231267
Solution - Subcutaneous
8 UNIT / 0.5 ML
11/17/1998
PEDIACEL
02243167
Suspension - Intramuscular
7 UNIT / 0.5 ML
10/4/2007
BOOSTRIX-POLIO
02312557
Suspension - Intramuscular
8 D / 0.5 ML
10/22/2010
QUADRACEL
02230946
Suspension - Intramuscular
8 UNIT / 0.5 ML
6/20/1997
INFANRIX-IPV/HIB
02257122
Suspension - Intramuscular
8 UNIT / 0.5 ML
10/25/2012
PENTACEL
02231343
Powder For Solution ,  Liquid - Intramuscular
8 UNIT / 0.5 ML
6/16/1997
TD POLIO ADSORBED
00615358
Suspension - Intramuscular
8 UNIT / 0.5 ML
12/31/1984
DT POLIO ADSORBED - SUS IM
aventis pasteur limited
02189127
Suspension - Intramuscular
8 UNIT / 0.5 ML
12/12/1996

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.